Titan Pharma (TTNP) Stock Price, Quote & News

Company Profile

Titan Pharmaceuticals, Inc. does not have significant operations. Previously, it was engaged in the development of therapeutics for the treatment of chronic diseases. Titan Pharmaceuticals, Inc. was founded in 1991 and is based in New York, New York.

Industry: Biotechnology

Sector: Healthcare

Phone: 650 244 4990

Website: www.titanpharm.com

Address:

10 East 53rd St., Suite 3001, New York, United States

Takeiteasy30 Jun. 13 at 5:53 PM

$TTNP Still quiet as hell. Mergers news 2 weeks ago. Tiny float - got a chance to shoot up out of nothing. Only lottery ticket here. Played $NLSP and $EYEN before with profit lets see what this brings

0 · Reply

Takeiteasy30 Jun. 9 at 6:18 PM

$TTNP Is no one playing this merger?? Float 1.1 mln lowest possible from all mergers - news was last week. $EYEN $NLSP

1 · Reply

Takeiteasy30 Jun. 5 at 1:00 PM

$TTNP Quiet there - with 33 K followers no one posting here. This merger play might shoot up at some point with this float - only small lottery added at that drop from few days ago.

0 · Reply

Surfude Jun. 3 at 1:08 PM

$TTNP --wait for volume. This move, up or down, means nothing until volume comes in.

0 · Reply

frankyboyz Jun. 3 at 1:06 PM

News, pump and wrecked trying some $TTNP 4.75’s will cut under 4.50’s Tight stops for me

1 · Reply

DARKP00L Jun. 3 at 12:58 PM

$TTNP 08:55 on Jun. 03 2025 Titan Pharmaceuticals Announces Filing By Black Titan Corporation With SEC For Previously Announced Proposed Combination Of Titan And TalenTec #tradeideas

0 · Reply

ahTony Jun. 3 at 12:53 PM

$TTNP float 1.33M

0 · Reply

DARKP00L Jun. 3 at 12:51 PM

$TTNP 08:49 on Jun. 03 2025 Titan Pharmaceuticals Announces Filing By Black Titan Corporation With SEC For Previously Announced Proposed Combination Of Titan And TalenTec #tradeideas

0 · Reply

premarketmaker Jun. 3 at 12:50 PM

$TTNP 6.95 HOD for the squeeze

0 · Reply

premarketmaker Jun. 3 at 12:49 PM

$TTNP low float - watch for new high of day- catalyst

0 · Reply

Titan Pharmaceuticals Announces Filing of Registration Statement for Proposed Business Combination with TalenTec Sdn. Bhd.

Apr 11, 2025, 4:15 PM EDT - 2 months ago

Titan Pharmaceuticals Announces $1 Million Private Placement of Convertible Preferred Stock

Nov 27, 2024, 4:05 PM EST - 7 months ago

Titan Pharmaceuticals, Inc. Announces Receipt of Notice from Nasdaq

Aug 22, 2024, 11:21 AM EDT - 10 months ago

TITAN PHARMACEUTICALS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Titan Pharmaceuticals, Inc. - TTNP

Aug 19, 2024, 4:11 PM EDT - 10 months ago

Titan Pharmaceuticals Enters Into Merger Agreement With KE Sdn. Bhd.

Jan 25, 2024, 4:29 PM EST - 1 year ago

Titan Pharmaceuticals Fully Compliant With NASDAQ Listing Criteria

Dec 28, 2023, 4:15 PM EST - 1 year ago

Titan Pharmaceuticals Announces Reverse Stock Split and Ratio

Oct 16, 2023, 4:37 PM EDT - 1 year ago

Titan Pharmaceuticals Announces Appointment of Dato' Seow Gim Shen and Brynner Chaim to the Company's Board of Directors

Sep 18, 2023, 7:30 AM EDT - 1 year ago

Titan Pharmaceuticals Announces $9.5 Million Private Placement of Convertible Preferred Stock

Jul 27, 2023, 7:30 AM EDT - 2 years ago

Titan Pharmaceuticals Announces Sale of Certain ProNeura Assets

Dec 15, 2022, 7:00 AM EST - 2 years ago

Titan Pharmaceuticals Provides Shareholder Update

Dec 12, 2022, 7:49 AM EST - 2 years ago

UPDATE -- Titan Pharmaceuticals Inc. Announces Licensing Agreement with Ocular Therapeutix Inc.

Aug 16, 2022, 10:53 AM EDT - 3 years ago

Titan Pharmaceuticals Announces Board Expansion and Management Changes

Jul 5, 2022, 8:00 AM EDT - 3 years ago

Titan Pharmaceuticals Announces FDA Clearance of IND Application for Nalmefene Implant

Jun 10, 2022, 8:00 AM EDT - 3 years ago

Activist Investing Discloses 9.9% Ownership Interest in Titan Pharmaceuticals, Inc.

Apr 25, 2022, 1:29 PM EDT - 3 years ago

Activist Investing Announces 5.6% Ownership Interest in Titan Pharmaceuticals, Inc.

Feb 2, 2022, 12:27 PM EST - 3 years ago

Titan Pharmaceuticals Raises $5.5M Via Equity

Feb 2, 2022, 8:45 AM EST - 3 years ago

Titan Pharmaceuticals Announces Pricing of $5.5 Million Registered Direct and PIPE Offering Priced At-The-Market

Dec 21, 2021, 8:00 AM EST - 3 years ago

Titan Pharmaceuticals to Explore Strategic Alternatives

Nov 8, 2021, 4:15 PM EST - 3 years ago

Sustained Anti-Pruritic Effect Of Titan's TP-2021 Implant Reported Today At Neuroscience 2021

Nov 5, 2021, 4:30 PM EDT - 3 years ago

Titan Announces Upcoming TP-2021 Implant Data Presentation at Neuroscience 2021

Oct 25, 2021, 7:15 AM EDT - 3 years ago

Titan Pharmaceuticals Receives Funding to Develop Combination HIV Therapeutic and Contraceptive Implant for Women in Developing Countries

Oct 12, 2021, 8:00 AM EDT - 3 years ago

Titan Pharmaceuticals and MUSC FRD Enter Into Research and Option License Agreement

Jun 23, 2021, 8:00 AM EDT - 4 years ago

Titan Announces Positive Results from the First Studies of TP-2021 Implant in an Established Animal Model of Chronic Pruritus

Mar 31, 2021, 4:30 PM EDT - 4 years ago

Titan Pharmaceuticals Announces Filing Of 2020 Annual Report On Form 10-K

Feb 1, 2021, 7:30 AM EST - 4 years ago

Positive Early Study Results Help Pave Wave for Titan Pharmaceuticals to Move Forward with its JT-09 ProNeura® Development Program

Jan 15, 2021, 9:15 AM EST - 4 years ago

Titan Pharmaceuticals Announces Pricing of $9.7 Million Registered Direct Offering

Nov 30, 2020, 12:50 PM EST - 4 years ago

Titan Pharmaceuticals Announces Reverse Stock Split

Nov 16, 2020, 8:45 AM EST - 4 years ago

Titan Pharmaceuticals Reports Third Quarter 2020 Financial Results

Oct 28, 2020, 3:00 PM EDT - 5 years ago

Titan Pharmaceuticals Announces Pricing of $8.0 Million Underwritten Public Offering

Oct 26, 2020, 6:30 AM EDT - 5 years ago

Titan Pharmaceuticals Announces Debt Settlement Agreement with Molteni and Horizon

Sep 18, 2020, 4:45 PM EDT - 5 years ago

Titan Pharmaceuticals' Stockholders Approve Proposal To Amend Its Certificate Of Incorporation

Sep 14, 2020, 8:30 AM EDT - 5 years ago

Titan Pharmaceuticals Provides Update To Stockholders On Proposal To Amend Its Certificate Of Incorporation

Aug 14, 2020, 7:08 PM EDT - 5 years ago

Titan Pharmaceuticals, Inc. (TTNP) CEO Sunil Bhonsle on Q2 2020 Results - Earnings Call Transcript

Aug 14, 2020, 8:45 AM EDT - 5 years ago

Titan Pharmaceuticals Reports Second Quarter 2020 Financial Results

Aug 10, 2020, 4:30 PM EDT - 5 years ago

Titan Pharmaceuticals To Report Second Quarter 2020 Financial Results On August 14, 2020

Jul 8, 2020, 8:00 AM EDT - 5 years ago

Titan Pharmaceuticals Urges Stockholders to Vote "FOR" Proposal to Amend Its Certificate of Incorporation

Jun 24, 2020, 8:00 AM EDT - 5 years ago

Titan Pharmaceuticals And Indegene Enter Into Probuphine® Co-Promotion Partnership

May 15, 2020, 8:30 PM EDT - 5 years ago

Titan Pharmaceuticals, Inc. (TTNP) CEO Sunil Bhonsle on Q1 2020 Results - Earnings Call Transcript

May 15, 2020, 8:45 AM EDT - 5 years ago

Titan Pharmaceuticals Reports First Quarter 2020 Financial Results

Mar 31, 2020, 12:43 PM EDT - 5 years ago

Penny Stocks to Buy Using Technical Analysis for April 2020

CPIX OSG

Mar 30, 2020, 7:43 PM EDT - 5 years ago

Titan Pharmaceuticals, Inc. (TTNP) CEO Sunil Bhonsle on Q4 2019 Results - Earnings Call Transcript

Nov 14, 2019, 10:16 PM EST - 6 years ago

Titan Pharmaceuticals, Inc. (TTNP) CEO Sunil Bhonsle on Q3 2019 Results - Earnings Call Transcript

Aug 14, 2019, 10:19 PM EDT - 6 years ago

Titan Pharmaceuticals, Inc. (TTNP) CEO Sunil Bhonsle on Q2 2019 Results - Earnings Call Transcript

Aug 14, 2019, 7:32 AM EDT - 6 years ago

Q2 Earnings Preview For Titan Pharmaceuticals

May 15, 2019, 9:56 PM EDT - 6 years ago

Titan Pharmaceuticals, Inc. (TTNP) CEO Sunil Bhonsle on Q1 2019 Results - Earnings Call Transcript

Apr 2, 2019, 12:50 PM EDT - 6 years ago

Titan Pharmaceuticals, Inc. (TTNP) CEO Sunil Bhonsle on Q4 2018 Results - Earnings Call Transcript

Takeiteasy30 Jun. 13 at 5:53 PM

0 · Reply

Takeiteasy30 Jun. 9 at 6:18 PM

$TTNP Is no one playing this merger?? Float 1.1 mln lowest possible from all mergers - news was last week. $EYEN $NLSP

1 · Reply

Takeiteasy30 Jun. 5 at 1:00 PM

$TTNP Quiet there - with 33 K followers no one posting here. This merger play might shoot up at some point with this float - only small lottery added at that drop from few days ago.

0 · Reply

Surfude Jun. 3 at 1:08 PM

$TTNP --wait for volume. This move, up or down, means nothing until volume comes in.

0 · Reply

frankyboyz Jun. 3 at 1:06 PM

News, pump and wrecked trying some $TTNP 4.75’s will cut under 4.50’s Tight stops for me

1 · Reply

DARKP00L Jun. 3 at 12:58 PM

$TTNP 08:55 on Jun. 03 2025 Titan Pharmaceuticals Announces Filing By Black Titan Corporation With SEC For Previously Announced Proposed Combination Of Titan And TalenTec #tradeideas

0 · Reply

ahTony Jun. 3 at 12:53 PM

$TTNP float 1.33M

0 · Reply

DARKP00L Jun. 3 at 12:51 PM

$TTNP 08:49 on Jun. 03 2025 Titan Pharmaceuticals Announces Filing By Black Titan Corporation With SEC For Previously Announced Proposed Combination Of Titan And TalenTec #tradeideas

0 · Reply

premarketmaker Jun. 3 at 12:50 PM

$TTNP 6.95 HOD for the squeeze

0 · Reply

premarketmaker Jun. 3 at 12:49 PM

$TTNP low float - watch for new high of day- catalyst

0 · Reply

OpenOutcrier Jun. 3 at 12:48 PM

$TTNP (+18.9% pre) Titan Pharmaceuticals Announces Filing of Registration Statement for Proposed Business Combination with TalenTec Sdn. Bhd. https://ooc.bz/l/66712

0 · Reply

RiskRewardLab Jun. 1 at 6:38 AM

$TTNP $TMBR $PRVB The weight loss sector is in a constant evolution and will some smaller companies will release new products that will change the game forever. GLMD is currently developping the next ozempic competitor with a much better advantage: using a pill instead of an injection.

0 · Reply

Reyes1027 May. 29 at 9:01 PM

$TTNP $8

0 · Reply

PenkeTrading May. 9 at 2:04 PM

I found you an Overbought RSI (Relative Strength Index) on the daily chart of Titan Pharmaceuticals Inc. Is that bullish or bearish? $TTNP #Titan #RsiOverbought #NASDAQ

0 · Reply

SirAskCheeks May. 9 at 12:51 PM

$TTNP this low floater walked up nicely on low volume yesterday. Keep an eye

0 · Reply

_www_larval_com_ May. 7 at 2:22 PM

$TTNP just shot 11% higher to 7% (~96Kv) a moment ago, follow for more volatility.

0 · Reply

topstockalerts Apr. 28 at 12:24 PM

Pre Market Top Gainers PT2 $AGMH $BATL $TTNP $YOSH $BON

0 · Reply

Whiskey1679 Apr. 27 at 5:26 PM

See my Profile for Fridays Winner!! CORRECTION!!! Made just over 40% with 2 trades on this one stock!!! Scroll down to 3:51 am Fridays pick. Cross refence check Pinned Post! Have a good Sunday folks!! Be on the hunt for a "$WGHTQ" 100% runner for tomorrow's Pick!!!! Friday's AH Gappers: $CASK $AMPY $TTNP $INTJ

1 · Reply

lecorb Apr. 11 at 8:51 PM

$TTNP https://seekingalpha.com/news/4430583-titan-pharmaceuticals-announces-1-million-private-placement?mailingid=39401108&messageid=2900&serial=39401108.224&source=email_2900&utm_campaign=rta-stock-news&utm_content=link-3&utm_medium=email&utm_source=seeking_alpha&utm_term=39401108.224

0 · Reply

NjordTrade Apr. 4 at 3:00 PM

$TTNP added

1 · Reply

NVDAMillionaire Mar. 27 at 10:45 AM

$TTNP Merger with TalenTec looks promising. Could be game-changer for TTNP. Watching closely for any updates on strategic alternatives. Might add small position if deal moves forward. Volatility expected but potential upside. notable article: https://beyondspx.com/article/titan-pharmaceuticals-a-company-in-transition-exploring-strategic-alternatives

0 · Reply

Vonheimler67 Feb. 28 at 6:22 PM

$TTNP

0 · Reply

Market Cap	4.07M
Revenue (ttm)	0.00
Net Income (ttm)	-4.71M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	0.00%
Debt to Equity Ratio	0.00

Volume	3,600
Avg Vol	43,870
Day's Range	N/A - N/A
Shares Out	914,000.00
Stochastic %K	30%
Beta	1.30
Analysts	Strong Buy
Price Target	$7.00